Penbutolol Pregnancy and Breastfeeding Warnings
Penbutolol is also known as: Levatol
Penbutolol Pregnancy Warnings
There are no reports of the use of penbutolol during pregnancy. As with other beta-blockers, it is recommended that newborns of mothers who were exposed to penbutolol near term or delivery be monitored for signs or symptoms of beta-blockade (bradycardia, hypotension, hypoglycemia) for at least 48 hours.
Penbutolol has been assigned to pregnancy category C by the FDA. Animal studies have revealed fetotoxicity only after extraordinary doses. No teratogenic effects were observed after rats and rabbits were given doses equivalent to 250 times the maximum recommended human dose, but a slight increase in intrauterine and 24-hour postpartum fetal death and decreased pup body weight and survival were observed after rats were given doses equivalent to 155 times the maximum recommended human dose. Fetotoxicity was not observed when lesser doses were given. There are no controlled data in human pregnancy. Penbutolol should only be given during pregnancy when benefit outweighs risk.
Penbutolol Breastfeeding Warnings
There are no data on the excretion of penbutolol into human milk. As with other beta-blockers, it is recommended that nursing infants whose mothers were exposed to penbutolol near term or delivery or who are taking penbutolol be monitored for signs or symptoms of beta-blockade (bradycardia, hypotension, hypoglycemia).
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.